Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride

Open access

Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride

The objective of the present research was to develop a bilayer tablet of propranolol hydrochloride using superdisintegrant sodium starch glycolate for the fast release layer and water immiscible polymers such as ethylcellulose, Eudragit RLPO and Eudragit RSPO for the sustaining layer. In vitro dissolution studies were carried out in a USP 24 apparatus I. The formulations gave an initial burst effect to provide the loading dose of the drug followed by sustained release for 12 h from the sustaining layer of matrix embedded tablets. In vitro dissolution kinetics followed the Higuchi model via a non-Fickian diffusion controlled release mechanism after the initial burst release. FT-IR studies revealed that there was no interaction between the drug and polymers used in the study. Statistical analysis (ANOVA) showed no significant difference in the cumulative amount of drug release after 15 min, but significant difference (p < 0.05) in the amount of drug released after 12 h from optimized formulations was observed.

Razvoj i vrednovanje dvoslojnih tableta propranolol hidroklorida

U radu je opisan razvoj dvoslojnih tableta propranolol hidroklorida, koristeći superdezintegrator škrob glikolat natrij u sloju za brzo oslobađanje i polimere koji se ne miješaju s vodom (etilceluloza, Eudragit RLPO i Eudragit RSPO) u sloju za usporeno oslobađanje. In vitro oslobađanje praćeno je u USP aparatu I te je uočeno početno naglo oslobađanje ljekovite tvari iza kojeg slijedi polagano oslobađanje tijekom 12 sati. In vitro kinetika oslobađanja prati Higouchijev model, dok mehanizam kontroliranog oslobađanja ne slijedi Fickov zakon poslije početnog naglog oslobađanja. FT-IR studije ukazuju da nema interakcije između ljekovite tvari i polimera upotrebljenih u oblikovanju. Statistička analiza (ANOVA) nije pokazala značajne razlike u kumulativnoj količini oslobođenog lijeka iz optimiranih formulacija poslije 15 minuta, ali polije 12 h još se ta količina značajno razlikovala (p < 0.05).

  • Martindale, The Extra Pharmacopoeia, 31st ed., The Pharmaceutical Press, London 1996, pp. 936-937.

  • M. J. Serlin, M. L. Orme, M. Maciver, G. J. Green, R. G. Sibeon and A. M. Beckenridge, Pharmacodynamics and pharmacokinetics of conventional and long acting propranolol in patients with moderate hypertension, J. Clin. Pharmcol.15 (1983) 519-526.

  • B. Taylan, Y. Capan, O. Guven, S. Kes and A. A. Hincal, Design and evaluation of sustained release and buccal adhesive propranolol hydrochloride tablets, J. Control. Rel.38 (1996) 11-20; DOI: 10.1016/0168-3654(95)00094-1.

  • M. A. Abraham and A. Shirwaikar, Formulation of multilayered sustained release tablets using insoluble matrix system, Indian J. Pharm. Sci.59 (1997) 312-315.

  • J. P. Vercammen, D. Dauwe and P. Brioen, Possibility of use of Eudragit RS as a sustained release matrix agent for the incorporation of water soluble active compounds at high percentages, STP Pharma. Sci.7 (1997) 491-497.

  • S. B. Jayaswa, K. D. Gode and S. K. Khanna, Sustained release tablet formulation of propranolol hydrochloride with Eudragit, Aust. J. Pharm. Sci.9 (1980) 22-26.

  • S. N. Makhija and P. R. Vavia, Once daily sustained release tablets of venlafaxine, a novel anti-depressant, Eur. J. Pharm. Biopharm.54 (2002) 9-15; DOI: 10.1016/S0939-6411 (02) 00049-8.

  • P. R. Katikaneni, S. M. Upadrashta, S. H. Neau and A. K. Mitra, Ethylcellulose matrix controlled release tablets of a water soluble drug, Int. J. Pharm.123 (1995) 119-125; DOI: 10.1016/0378-5173 (95)00060-V.

  • G. Shlieout and G. Zessin, Investigation of ethylcellulose as a matrix former and a new method to regard and evaluate the compaction data, Drug Dev. Ind. Pharm.22 (1996) 313-319.

  • I. Pather, I. Russell, J. A. Syce and S. H. Neau, Sustained release theophylline tablets by direct compression, Part 1: formulation and in vitro testing, Int. J. Pharm.164 (1998) 1-10; DOI: 10.1016/ S0378-5173(97)00348-7.

  • S. M. Upadrashta, P. R. Katikaneni, G. A. Hileman and P. R. Keshary, Direct compression controlled release tablets using ethylcellulose matrices, Drug Dev. Ind. Pharm.199 (1993) 449-460.

  • E. A. Rawlins, Formulation, in Bentley's Text Book of Pharmaceutics, 8th ed., Bailliere Tindall, London 1996, pp. 663-666.

  • K. E. Thummel, D. D. Shen, N. Isoherranen and H. E. Smith, Design and Optimization of Dosage Regimens; Pharmacokinetic Data, in Goodman and Gilman's The Pharmacological Basis of Therapeutics, 11th ed. (Eds. L. L. Bruton, J. S. Laro and K. L. Parker), McGraw-Hill Medical Publishing Division, London 2006, pp. 1863.

  • J. Staniforth, Powder Flow, in Pharmaceutics - the Science of Dosage Form Design, 2nd ed. (Ed. M. E. Aulton), Churchill Livingstone, London 2002, pp. 207-208.

  • A. Martin, P. Bustamante and A. Chun, Micromeritics, in Physical Pharmacy-Physical Chemical Principles in the Pharmaceutical Sciences, 4th ed., Lippincott Williams and Wilkins, Baltimore 2002, pp. 446-448.

  • H. C. Ansel, L. V. Allen and N. G. Popovich, Capsules and Tablets, in Pharmaceutical Dosage Forms and Drug Delivery Systems, 7th ed., Lippincott Williams & Wilkins, Philadelphia 2002, pp. 204-209.

  • USP 24/NF 19, USP Convention, Rockville 1999, pp. 1429.

  • H. A. Merchant, H. M. Shoaib, J. Tazeen and R. I. Yousuf, Once-daily tablet formulation and in vitro release evaluation of cefpodoxime using hydroxypropyl methylcellulose: A technical note, AAPS Pharm. Sci. Tech.7 (2006) Article 78; DOI: 10.1028/pt 070378.

  • D. W. Bourne, Pharmacokinetics, in Modern Pharmaceutics, 4th ed. (Eds. G. S. Banker and C. T. Rhodes), Marcel Dekker, New York 2002, pp. 67-92.

  • T. Higuchi, Mechanism of sustained action medication, J. Pharm. Sci.52 (1963) 1145-1149.

  • R. W. Korsmeyer, R. Gurny, E. Docler, P. Buri and N. A. Peppas, Mechanism of solute release from porous hydrophilic polymers, Int. J. Pharm.15 (1983) 25-35; DOI: 10.1016/0378-5173(83) 90064-9.

  • A. Stamm and J. C. Tritsch, Some consideration on the liberation of drugs from inert matrices, Drug Dev. Ind. Pharm.12 (1986) 2337-2353.

  • C. S. Lafuente, M. T. Fauci, M. F. Arevelo, J. A. Fuentes, A. M. Rabasco and P. Mura, Development of sustained release tablets of didanosine containing methacrylic and ethylcellulose polymers, Int. J. Pharm.234 (2002) 213-221; DOI. 10.1016/S0378-5173(10)00962-0.

  • M. Guyot and F. Fawaz, Nifedipine loaded polymeric microspheres: preparation and physical characteristics, Int. J. Pharm.175 (1998) 61-74; DOI: 10.1016/S0378-5173(98)00253-1.

  • N. A. Peppas, Analysis of Fickian and non Fickian drug release from polymers, Pharm. Acta Helv.60 (1985) 110-111.

  • J. Akubuga, Preparation and evaluation of controlled release furosemide microspheres by spherical crystallization, Int. J. Pharm.53 (1989) 99-105; DOI: 10.1016/0378-5173(89)90233-0.

  • Y. Kawashima, T. Niwa, T. Handa, H. Takeuchi, T. Iwamoto and K. Itoh, Preparation of controlled release microspheres of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion, J. Pharm. Sci.78 (1989) 68-72.

  • S. Haznedar and B. Dortunc, Preparation and in vitro evaluation of eudragit microspheres containing acetazolamide, Int. J. Pharm.269 (2004) 131-140; DOI: 10.1016/J.ijpharm.2003.09.015.

Acta Pharmaceutica

The Journal of Croatian Pharmaceutical Society

Journal Information

IMPACT FACTOR 2016: 1.288
5-year IMPACT FACTOR: 1.600

CiteScore 2016: 1.55

SCImago Journal Rank (SJR) 2016: 0.353
Source Normalized Impact per Paper (SNIP) 2016: 0.854


All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 21 21 21
PDF Downloads 6 6 6